Self-testing for asymptomatic non-contacts using rapid antigen tests-is this leading to a cost effective reduction in infection transmission?
BMJ
.
2022 Feb 23:376:o445.
doi: 10.1136/bmj.o445.
Authors
Angela E Raffle
1
,
Mike Gill
2
Affiliations
1
University of Bristol Population Health Sciences and UK National Screening Programmes, Bristol, UK.
2
London, UK.
PMID:
35197303
DOI:
10.1136/bmj.o445
No abstract available
MeSH terms
Asymptomatic Infections*
COVID-19 / prevention & control*
COVID-19 Serological Testing / methods*
Cost-Benefit Analysis*
Humans
Pandemics
Self-Testing*